Document Detail


Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in Type 2 diabetes.
MedLine Citation:
PMID:  22892126     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BackgroundPeroxisome proliferator-activated receptor (PPAR)-δ is a ligand-activated transcription factor in regulating gene expression and is believed to play an important role in various kidney diseases including diabetic nephropathy. This study investigated the efficacy of GW610742, a highly specific agonist for PPAR-δ, for the treatment of diabetic nephropathy.MethodsType 2 diabetic Otsuka Long-Evans Tokushima Fatty rats were randomized into an untreated diabetic group (n= 9) and a GW610742-treated diabetic group (n= 9). The GW610742 was administered (10 mg/kg/day) orally for 11 weeks. Long-Evans Tokushima Otsuka rats (n= 9) were used as a non-diabetic control.ResultsAlbuminuria was markedly increased and renal PPAR-δ expression was decreased in diabetes. Diabetic albuminuria and renal injury markers, such as glomerular basement membrane thickening, decreased number of slit pores between podocyte foot processes, decreased nephrin expression, increased desmin expression and increased CCL2 expression, were significantly reversed through the treatment with GW610742. PPAR-δ agonist GW610742 markedly increased nephrin expression in cultured podocytes. Nephrin mRNA expression was markedly decreased in response to high glucose in cultured podocytes and effectively prevented by GW610742.ConclusionsPPAR-δ activation by GW610742 ameliorates albuminuria by preventing diabetes-induced nephrin loss and restoring podocyte integrity, implying that GW610742 may be a potential therapeutic agent for diabetic nephropathy.
Authors:
Eun Young Lee; Geun Tae Kim; Miri Hyun; Suji Kim; Sujin Seok; Ran Choi; Mi Young Lee; Choon Hee Chung
Related Documents :
22785236 - The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes...
22799126 - Effect of periodontal therapy on metabolic control and an inflammatory mediator in type...
8636416 - Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in dia...
6997676 - Effects of insulin at two dose levels on gluconeogenesis from alanine in fasting man.
21342106 - Non-invasive imaging of ferucarbotran labeled ins-1e cells and rodent islets in vitro a...
8461976 - Vagolytic effect of diabetes mellitus.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-14
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  -     ISSN:  1460-2385     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Department of Internal Medicine, Soon Chun Hyang University Cheonan Hospital, Cheonan, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular dynamics simulation of HIV-1 fusion domain-membrane complexes: Insight into the N-terminal...
Next Document:  Ultra-violet B (UVB)-induced skin cell death occurs through a cyclophilin D intrinsic signaling path...